The 3D-QSAR study of antitumor arylsulfonylimidazolidinone derivatives by CoMFA and CoMSIA

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 21, 2003, Pages 4585-4589

  Choo, Hea Young Park ^a   Choi, Suyoung ^a   Jung, Sang Hun ^b   Koh, Hun Yeong ^c   Pae, Ae Nim ^c  

^a Ewha Womans University   (South Korea)

^b Chungnam National University   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMIDAZOLINE DERIVATIVE;

ANALYTICAL ERROR; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; ELECTRICITY; ELECTROCHEMICAL ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CARCINOMA; MOLECULAR DYNAMICS; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STANDARD; STATISTICAL MODEL; STEREOSPECIFICITY; THREE DIMENSIONAL QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP; VALIDATION PROCESS;

EID: 0141615706     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00530-3     Document Type: Article

References (17)

1. Houghton P.J., Houghton J.A. Investig. New Drugs. 14:1996;271.
2. Howbert J.J. Drugs Future. 16:1991;517.
3. Ehjardt W.J. J. Drug Metab. Dispos. 19:1991;370.
4. Jung S.H., Song J.S., Lee H.S., Choi S.U., Lee C.O. Bioorg. Med. Chem. Lett. 6:1996;2553.
5. Jung S.H., Song J.S., Lee H.S., Choi S.U., Lee C.O. Arch. Pharm. Res. 19:1996;570.
6. Jung S.H., Kwak S.J. Arch. Pharm. Res. 20:1997;283.
7. Jung S.H., Lee H.S., Song J.S., Kim W.M., Han S.B., Lee C.W., Lee M.S., Choi D.R., Lee J.A., Chung Y.H., Yoon S.J., Moon E.Y., Hwang H.S., Seong S.K., Lee D.K. Bioorg. Med. Chem. Lett. 8:1998;1547.
8. Moon E.Y., Choi C.H., Seong S.K., Lee J., Ryu J.M., Lee M., Jung S.H., Chung Y.H., Lee D.K., Yoon S.J. J. Appl. Pharmacol. 6:1998;395.
9. Moon E.Y., Seong S.K., Jung S.H., Lee M., Lee D.K., Rhee D.K., Pyo S., Yoon S.J. Cancer Lett. 140:1999;177.
10. Moon E.Y., Hwang H.S., Choi C.H., Jung S.H., Yoon S.J. Arch. Phar. Res. 22:1999;565.
11. Hwang H.S., Moon E.Y., Seong S.K., Choi C.H., Chung C.H., Jung S.H., Yoon S.J. Anticancer. Res. 19:1999;5087.
12. Jung S.H., Kwak S.J., Kim N.D., Lee S.U., Lee C.O. Arch. Phar. Res. 23:2000;35.
13. Lee H.S., Park K.L., Choi S.U., Lee C.O., Jung S.H. Arch. Pharm. Res. 23:2000;579.
14. Kim I.W., Jung S.H. Arch. Pharm. Res. 25:2002;421.
15. Park K.L., Moon B.G., Jung S.H., Kim J.G., Suh I.H. Acta Crystal. C56:2000;1247.
16. Yoon, S. J.; Chung, Y. H.; Lee, M. S.; Choi, D. R.; Lee, J. A.; Lee, H. S.; Yun, H. R. Lee, D. K.; Moon, E. Y.; Hwang, H. S.; Choi, C. H.; Jung, S. H. WO 98/07719, PCT/KR 97/00154.
17. Klebe G., Abraham U., Mietzner T. J. Med. Chem. 37:1994;4130.